• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

2 years ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Bithumb Sets IPO Roadmap for 2028 Amid Regulatory Challenges

chest

Bithumb has announced a three-stage plan to prepare for a stock market listing by 2028, focusing on internal control upgrades and compliance.

user avatarTando Nkube

Backpack Exchange Expands Trading Options with TRON Listing

chest

Backpack Exchange has listed TRON (TRX) for spot and perpetual trading, introducing TRXUSD and TRXPERP markets.

user avatarKofi Adjeman

Bitcoin's Price Struggles Amid Market Challenges

chest

Bitcoin has been on a downward trend since late 2025, with various factors affecting its price.

user avatarNguyen Van Long

Solana's CISO Warns of AI-Driven Crypto Scams

chest

Michael Coates, the new Chief Information Security Officer of Solana, warns about the rising threat of AI-driven crypto scams that are becoming more sophisticated and targeting individuals directly.

user avatarSatoshi Nakamura

XRP Ledger Operators Urged to Upgrade to xrpld v321

chest

XRP Ledger operators are urged to upgrade to xrpld v321 following a hotfix for validator manifest flooding, which caused high memory and bandwidth usage on nodes.

user avatarJesper Sørensen

Sponsored Fees and MPT Features to Enhance User Experience

chest

The v330 release will introduce Sponsored Fees and improvements to MultiPurpose Tokens (MPT) to streamline user interactions with the XRP Ledger.

user avatarRajesh Kumar

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.